Drug Shortage Report for BREVICON 1/35 TABLETS (21-DAY PACK)

Last updated on 2025-02-04 History
Report ID 230652
Drug Identification Number 02189054
Brand name BREVICON 1/35 TABLETS (21-DAY PACK)
Common or Proper name BREVICON 1/35
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) ETHINYL ESTRADIOL NORETHINDRONE
Strength(s) 0.035MG 1MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 1x21 BLST
ATC code G03AA
ATC description HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-09-01
Actual start date 2024-10-03
Estimated end date 2025-02-19
Actual end date 2025-02-03
Shortage status Resolved
Updated date 2025-02-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2025-02-04 English Compare
v15 2025-02-03 French Compare
v14 2025-02-03 English Compare
v13 2025-01-14 French Compare
v12 2025-01-14 English Compare
v11 2024-11-07 French Compare
v10 2024-11-07 English Compare
v9 2024-10-07 French Compare
v8 2024-10-07 English Compare
v7 2024-09-02 English Compare
v6 2024-07-31 French Compare
v5 2024-07-31 English Compare
v4 2024-06-14 French Compare
v3 2024-06-14 English Compare
v2 2024-06-14 French Compare
v1 2024-06-14 English Compare

Showing 1 to 16 of 16